Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human NGFI-B alpha/Nur77/NR4A1 Antibody, R&D Systems™

Mouse Monoclonal Antibody has been used in 2 publications
Supplier: R&D Systems PPH164800
This item is not returnable.
View return policy
Description
NGFI-B alpha/Nur77/NR4A1 Monoclonal specifically detects NGFI-B alpha/Nur77/NR4A1 in Human samples. It is validated for Western Blot, Immunoprecipitation, Direct ELISA.Specifications
NGFI-B alpha/Nur77/NR4A1 | |
Monoclonal | |
Unconjugated | |
A liquid formulation in physiologic saline with 0.1% NaN 3 . with 0.1% Sodium Azide | |
NR4A1 | |
Recombinant human NGFI-B alpha/Nur77/NR4A1 aa 2-249 | |
100 μg | |
Primary | |
This antibody specifically recognizes human NGFI-B alpha but does not recognize NGFI-B beta and gamma . Not yet tested in other species. | |
This antibody is stable for greater than six months when held at -20 degreesC in a manual defrost freezer or at -70 degreesC. Upon thawing, the antibody can be stored at 2-8 degreesC for at least 1 month without detectable loss of activity. Avoid repeated freeze-thaw cycles. | |
IgG2a |
Western Blot, Immunoprecipitation, ELISA | |
H1648 | |
Western Blot, Immunoprecipitation, Direct ELISA | |
Early response protein NAK1, GFRP1ST-59, growth factor-inducible nuclear protein N10, HMR, HMRNP10, hormone receptor, MGC9485, N10, NAK1, NAK-1, NGFIB, NGFIB alpha, NR4A1, Nuclear hormone receptor NUR/77, nuclear receptor subfamily 4 group A member 1, nuclear receptor subfamily 4, group A, member 1, NUR77, Orphan nuclear receptor HMR, Orphan nuclear receptor TR3, steroid receptor TR3, Testicular receptor 3, TR3, TR3 orphan receptor | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
3164 | |
Human | |
Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction